| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3164a963ca21cec1151213cb1bb95e77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbffa3b81b3b862dc7220b5648f5f745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3163957db744d0171ae3ff8ab14f0d5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1824 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 |
| filingDate |
2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e30fefd7df97b76ccf2850c4bc88dfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d77149aa8d68a97dbc3e9a04f6bdc42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efed22610b04ee55d0f1c57e83083dac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e841f37f5784645f497919d258e289db |
| publicationDate |
2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160056492-A |
| titleOfInvention |
Chitosan nanoparticle complex for atherosclerosis diagnosis, preparation method thereof and contrast media composition comprising the same |
| abstract |
The present invention relates to a chitosan nanoparticle complex for the diagnosis of atherosclerosis, a method for producing the same, and a contrast agent composition containing the same. The chitosan nanoparticle complex according to the present invention can target and recognize inflammatory macrophages present in atherosclerotic plaque. It is also possible to evaluate the degree of inflammation present in the arteriosclerotic plaque only by targeting the macrophages to the chitosan nanoparticle complex. Therefore, when the chitosan nanoparticle complex according to the present invention is used as a contrast agent, it is possible to diagnose arteriosclerosis, and to diagnose the progress of arteriosclerosis through the degree of inflammation even before the stenosis due to arteriosclerosis And it becomes possible to diagnose or prevent various complications due to arteriosclerosis early. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200041703-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973927-B2 |
| priorityDate |
2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |